Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 5/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Asperuloside SCHEMBL308265 | 0.90 | STAT3 (0.42) | STAT3ELANEL3MBTL1PTPN1MAPT | |
| Asperuloside SCHEMBL31666329 | 0.90 | STAT3 (0.42) | STAT3ELANEL3MBTL1PTPN1MAPT | |
| Asperuloside SCHEMBL308266 | 0.90 | STAT3 (0.42) | STAT3ELANEL3MBTL1PTPN1MAPT | |
| SCHEMBL422234 | 0.90 | ELANE (0.41) | STAT3ELANEL3MBTL1PTPN1MAPT | |
| SCHEMBL419331 | 0.90 | ELANE (0.41) | STAT3ELANEL3MBTL1PTPN1MAPT | |
| SCHEMBL29426053 | 0.88 | ELANE (0.44) | STAT3ELANEL3MBTL1PTPN1MAPT | |
| SCHEMBL424543 | 0.88 | ELANE (0.44) | STAT3ELANEL3MBTL1PTPN1MAPT | |
| Deacetylasperuloside SCHEMBL29367563 | 0.85 | L3MBTL1 (0.53) | STAT3ELANEL3MBTL1PTPN1MAPT | |
| SCHEMBL29425770 | 0.83 | STAT3 (0.41) | STAT3ELANEL3MBTL1MAPTMEN1 | |
| Paederosidic Acid SCHEMBL424808 | 0.81 | MAPT (0.50) | STAT3ELANEL3MBTL1PTPN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350407-B | Template molecule, molecular imprinting material and application thereof in separation of iridoid glycoside compounds | 广州伽能生物科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119733034-A | Compound preparation for promoting fracture regeneration and healing and preparation method thereof | 广东省中医院海南医院 | 2025-04-01 | — | — | CN | claimed |
| CN-119350407-A | Template molecule, molecular imprinting material and application thereof in separation of iridoid glycoside compounds | 广州伽能生物科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-118872683-A | New application of plant source glycoside compound | 华中农业大学 | 2024-11-01 | — | — | CN | claimed |
| CN-117214371-A | Detection method of enteritis treating preparation | 江西康恩贝天施康药业有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-112047988-B | Paederoside monomer compound, preparation method and application thereof | 宁波大昌药业有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-114886907-A | (E) Application of-6-O-p-coumaroyl paederosidic methyl ester in preparation of medicine for preventing/treating liver injury | 山东中医药大学附属医院 | 2022-08-12 | — | — | CN | claimed |
| CN-114456142-A | Method for extracting anti-tumor component from oldenlandia diffusa | 江苏医药职业学院 | 2022-05-10 | — | — | CN | claimed |
| CN-111670037-B | Oldenlandia diffusa anti-tumor effective component and preparation method and application thereof | 广东新纪元生命科技有限公司 | 2022-04-26 | — | — | CN | claimed |
| CN-110898116-B | Paederia scandens extract and separation preparation method and application thereof | 广西壮族自治区中医药研究院 | 2022-04-15 | — | — | CN | claimed |
| CN-106668241-A | External preparation of paederia scandens extract for treating haemorrhoids | 李仲昆 | 2017-05-17 | — | — | CN | claimed |
| CN-104474068-A | Paederia scandens extractive and application thereof | NINGBO DACHANG PHARMACEUTICAL CO LTD | 2015-04-01 | — | — | CN | claimed |
| CN-104435226-A | Paederia scandens extract and application thereof | NINGBO DACHANG PHARMACEUTICAL CO LTD | 2015-03-25 | — | — | CN | claimed |
| CN-104398619-A | Fevervine extract and applications thereof | NINGBO DACHANG PHARMACEUTICAL CO LTD | 2015-03-11 | — | — | CN | claimed |
| CN-102846784-B | Paederia scandens water extract, and preparation method and application thereof | NINGBO DACHANG PHARMACEUTICAL CO., LTD. (CN) | 2014-10-01 | — | — | CN | claimed |
| CN-104072554-A | Method for extracting paederia scandens from fevervine | NANJING ZELANG MEDICAL TECH CO | 2014-10-01 | — | — | CN | claimed |
| CN-102846784-A | Paederia scandens water extract, and preparation method and application thereof | NINGBO DACHANG PHARMACEUTICAL CO LTD | 2013-01-02 | — | — | CN | claimed |
| CN-101156913-A | Application of fevervine iridoid glycosides and its preparation | LANLAN ZHOU (CN) | 2008-04-09 | — | — | CN | claimed |
| CN-101049360-A | Preparation of Chinese traditional medicine for treating gout disease, and application of extractive of Chinese feveruine | ZHOU LANLAN (CN) | 2007-10-10 | — | — | CN | claimed |
| US-4410710-A | Conversion of iridoids to prostaglandins | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 1983-10-18 | — | — | US | claimed |